December 29, 2007

Heart safety of non-heart drugs questioned

A New York heart surgeon is calling for more testing to ensure the cardiovascular safety of drugs developed primarily for non-cardiovascular medical problems.

Dr. Jeffrey Borer of NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York said regulatory bodies should also have the authority to mandate continuing evaluation of drug effects, even after drugs are approved for marketing.

"The importance of evaluating the cardiovascular safety of new drugs has been highlighted by recent examples of drugs -- anti-arthritis drugs and others -- that were withdrawn from the market when unacceptable cardiovascular risks were discovered after regulatory approval," Borer said Friday in a release.

Borer's recommendations, made recently at the European Society of Cardiology in Vienna, were drawn in part from an August 2007 article in the European Heart Journal.

Copyright 2007 by United Press International

Citation: Heart safety of non-heart drugs questioned (2007, December 29) retrieved 20 April 2024 from https://medicalxpress.com/news/2007-12-heart-safety-non-heart-drugs.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Where patients live impacts whether they pick up their heart-failure medications
 shares

Feedback to editors
Researchers develop a new way to safely boost immune cells to fight cancer

12 hours ago
New compound from blessed thistle may promote functional nerve regeneration

12 hours ago
New research defines specific genomic changes associated with the transmissibility of the mpox virus

12 hours ago
New study confirms community pharmacies can help people quit smoking

12 hours ago
Researchers discover glial hyper-drive for triggering epileptic seizures

13 hours ago
Deeper dive into the gut microbiome shows changes linked to body weight

13 hours ago
A new therapeutic target for traumatic brain injury

13 hours ago
Dozens of COVID virus mutations arose in man with longest known case, research finds

13 hours ago
Researchers explore causal machine learning, a new advancement for AI in health care

13 hours ago
Analyzing the progression in retinal thickness could predict cognitive progression in Parkinson's patients

13 hours ago
Load comments (0)